Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obese Adult Participants at Risk of Cardiovascular Disease”

2 trials

Showing 2 of 2 results

Large-scale testing (Phase 3)Study completedNCT05803421
What this trial is testing

Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Who this might be right for
Type 2 DiabetesObesityOverweight or Obesity+3 more
Eli Lilly and Company 2,749
Early research (Phase 1)Looking for participantsNCT07581431
What this trial is testing

A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969

Who this might be right for
Healthy Subjects (HS)Obese Adult Participants at Risk of Cardiovascular Disease
InSilico Medicine Hong Kong Limited 100

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation